Imaging Diagnostic Systems showcases CT Laser Breast imaging system at RSNA 2010

NewsGuard 100/100 Score

Imaging Diagnostic Systems, Inc., (OTCBB:IMDS), a pioneer in laser optical breast imaging, announced today that it is exhibiting its CTLM system at the 96th RSNA 2010 Scientific Assembly and Annual Meeting, November 29th - December 2nd in Chicago, Illinois. The company is located at booth #4419 in Hall A of the North Building.

RSNA is the world's largest annual radiology meeting with more than 40,000 medical imaging members consisting of radiologist, radiation oncologists, medical physicists and allied scientists.

On November 22, 2010 the company submitted a Premarket Notification 510 (k) application to the Food and Drug Administration seeking United States marketing clearance for its CT Laser Breast imaging (CTLM) system.

Attendance for the 96th RSNA Scientific Assembly is expected to reach about 100,000 with medical professionals from all over the world and 650 healthcare companies exhibiting; remaining the top radiology exhibition in the U.S.

The CTLM system has received certification and licenses for the European CE marking, CMDCAS Canadian Health screening, China SFDA, UL, ISO 13485.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Ultrahigh-spatial-resolution PCD-CT improves assessment of coronary artery disease